secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2023-12-19T23:59:59+00:00
Accession:  0001213900-23-096921
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 4.02
LLM model:  deepseek-v4-flash:cloud@v2

Envoy Medical restating Q3 2023 financials due to FPA accounting error; prior statements no longer reliable
--------------------------------------------------------------------------------

- Audit committee on Dec 14, 2023 concluded Q3 2023 unaudited financials should no longer be relied upon.
- Error in accounting for forward purchase agreement (FPA); prepayment to be reclassified from assets to equity.
- Restatement will also record maturity and share consideration as non-current liabilities.
- Material weakness in internal control over financial reporting as of Sept 30, 2023, previously disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000121390023096921/0001213900-23-096921-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000121390023096921/ea190283-8k_envoy.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-096921

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer